EXHIBITOR & SPONSOR PROSPECTUS

7TH INTERNATIONAL SYMPOSIUMAPRIL 20-22, 2017HOLIDAY INN GOLDEN GATEWAY, SAN FRANCISCO, USA

E-mail: joefner@cancermetastasis.org

SPONSORED BY THE SENTINEL NODE ONCOLOGY FOUNDATION

www.cancermetastasis.org

CANCER METASTASIS THROUGH THE LYMPHOVASCULAR SYSTEM:

BIOLOGY & TREATMENT

ABOUT THE CONGRESSSPONSORED BY THE SENTINEL NODE ONCOLOGY FOUNDATION

The Symposium is sponsored by the Sentinel Node Oncology Foundation (SNOF) whose mission is to advance the care and treatment of patients with solid cancer and to help develop new preventative strategies, diagnostics, and treatments. It is now known that the same type of cancer is different from one person to the other. After decades of research, we are poised to enter a new era of medical practice where detailed genetic and other molecular information about a patient's cancer is routinely used to deploy effective, patient-specific reme-dies to treat it. We are about to enter the era of precision medicine (NCI and NIH Precision Medicine Initiative®).

This CME accredited program was developed to provide a forum for discussing and presenting pre-clinical, translational and clinical re-search and thereby improve understanding, diagnosis, treatment, and quality of life of patients suffering from cancer as well as explore emerging diagnostic tools and patient-specific treatments for cancer. Recent developments in understanding the cancer microenviron-ment and the molecular mechanisms involved in the progression of cancer cells to metastasis will be discussed. Participants will acquire knowledge on cutting edge lymphatic system imaging (including sentinel node imaging), lymph/hemangiogenesis, lymphocyte trafficking and late-breaking immunomodulation approaches and the latest innovations in molecular imaging of cancer metastasis. Studies of biomarkers and their diagnostic and prognostic applications in cancer progression and metastatic cancer, as well as their usefulness in ra-dio imaging and molecular targeted therapy will also be significant parts of the Symposium. Promising results of recent clinical trials of emerging therapies including targeted therapy and checkpoint inhibition will be reviewed. Lymphedema, a significant complication of cancer treatment, will be addressed and the current treatment of lymphedema will be updated.

Target Audience: Based on the attendance history we anticipate 350-400 participants, a collegial atmosphere with ample opportunity to network and meet with every attendee with a potential interest in your product or services. These attendees will be primarily physicians (65%) specializing in surgery, oncology, molecular imaging, plastic surgery, radiation oncology, thoracic medicine with the remainder a mix-ture of predominately PhD/scientists from both academia and biotechnology as well as a smaller groups of attendees who are in training, regulatory or from industry.

Virtual Meeting: Most of the Live Presentations will be captured on video with the slide presentations synchronized in a side by side for-mat to be accessible on the cancermetastasis.org website following the live meeting. Please review the program and the information in this prospectus and contact Joan Oefner to discuss your participation. We are happy to customize a sponsorship package based on your com-pany?s specific needs and requirements.

KEYNOTE SPEAKERS

ORGANIZING COMMITTEE: STANLEY P.L. LEONG, MD, SYMPOSIUM CHAIR, California Pacific Medical Center, San Francisco, USA

MICHAEL J. BERNAS, MS, University of Arizona, Tuscon, USA

DALE HAN, MD, Yale School of Medicine, New Haven, USA

DAVE S. B. HOON, PHD, John Wayne Cancer Institute, Santa Monica, USA

MOHAMMED KASHANI-SABET, MD, California Pacific Medical Center, San Francisco, USA

KEVIN KIM, MD, California Pacific Medical Center, San Francisco, USA

DONALD M. MCDONALD, MD, PHD, University of California, San Francisco, USA

DAVID NATHANSON, MD, Henry Ford Health System , Detroit, USA

BARBARA POCKAJ, MD, Mayo Clinic, Phoenix, USA

DOUGLAS S. REINTGEN, MD, University of South Florida, Tampa, USA

SASKIA R.J. THIADENS, RN, San Francisco, USA

RICHARD L. WHITE, JR, MD, Carolinas HealthCare System, Charlotte, USA

MARLYS H. WITTE, MD, University of Arizona, Tuscon, USA

JONATHAN S. ZAGER, MD, Moffitt Cancer Center, Tampa, USA

PRELIMINARY LIST OF CONFIRMED FACULTY

Roy E. Abendroth, MD, California Pacific Medical Center, San Francisco, USA

Athena Aktipis, PhD, Arizona State University, Tempe , USA

Charles M. Balch, MD, University of Texas MD Anderson Cancer Center, Houston, USA

Jai Balkissoon, MD, FACS, PPD, Berkeley, USA

Michael J. Bernas, MS, University of Arizona, Tuscon, USA

Marcus W. Bosenberg, PhD, Yale School of Medicine, New Haven, USA

John K. Chan, MD, California Pacific Medical Center, San Francisco, USA

Michael Dellinger, PhD, UT Southwestern Medical Center, Dallas, USA

Mark B. Faries, MD, John Wayne Cancer Institute, Santa Monica, USA

John V. Frangioni, MD, PhD , The Curadel Companies, Marlborough, USA

Sanjiv Sam Gambhir, MD, PhD, Stanford University School of Medicine, Stanford, USA

Dale Han, MD, Yale School of Medicine, New Haven, USA

Dave S. B. Hoon, PhD, John Wayne Cancer Institute, Santa Monica, USA

Charles C. Hsu, MD, PhD, University of Arizona, Tucson, USA

Mohammed Kashani-Sabet, MD, California Pacific Medical Center, San Francisco, USA

Kevin Kim, MD, California Pacific Medical Ctr, San Francisco, USA

Harriet Kluger, MD, Yale School of Medicine, New Haven, USA

Henry M. Kuerer, MD, PhD, University of Texas MD Anderson Cancer Center, Houston, USA

David Krag, MD, University of Vermont, Burlington, USA

Stanley P.L. Leong, MD, Symposium Chair, California Pacific Medical Ctr, San Francisco, USA

Carlo C. Maley, PhD, Arizona State University, Tempe, USA

Donald M. McDonald, MD, PhD, University of California, San Francisco, USA

Funda Meric-Bernstam, MD, University of Texas MD Anderson Cancer Center, Houston, TX

Nobel Laureate W.E. Moerner, PhD, Stanford University, Stanford, USA

Nicola Mozzillo, MD, National Cancer Institute of Naples, Naples, Italy

S. David Nathanson, MD, Henry Ford Health System , Detroit, USA

Lisa A. Newman, MD, MPH ,Henry Ford Health System, Detroit, USA

David R. Parkinson, MD, Essa Pharmaceuticals, Inc.,Vancouver, Canada

Barbara Pockaj, MD, Mayo Clinic, Phoenix, USA

Douglas S. Reintgen, MD, University of South Florida, Tampa, USA

Hope S. Rugo, MD, University of California San Francisco, San Francisco, USA

Baldassarre Stea, MD, PhD, University of Arizona, Tuscon, USA

Alessandro Testori, MD, Istituto Europeo di Oncologia, Milano, Italy

Saskia R.J. Thiadens, RN, Founder National Lymphedema Network, San Francisco, USA

Mona Wan, MS, MBA, Stanford University, Stanford, USA

Richard L. White, Jr, MD, Carolinas HealthCare System, Charlotte, USA

Marlys H. Witte, MD, University of Arizona, Tuscon, USA

Isaac P. Witz, PhD, Tel Aviv University, Tel Aviv, Israel

Jonathan S. Zager, MD, Moffitt Cancer Center, Tampa, USA

INDUSTRY SUPPORT OPPORTUNITIES

EXHIBIT SPACE: (SPACE IS LIM ITED TO 18 TABLETOPS) - TABLETOP EXHIBIT BOOTH WITH 2 BADGES, $5,000 - TABLETOP EXHIBIT BOOTH WITH 1 BADGE,    $4,250 - NON-PROFIT TABLETOP WITH 1 BADGE,       $2,500 - LITERATURE ONLY TABLE IN FOYER,             $1,500

EXHIBITS INCLUDE ONE 6? X 30? DRAPED TABLE WITH TWO CHAIRS.

Setup of exhibits is on Wednesday, April 19, 2017 from 6:00 ? 9:00 PM and Thursday from 6:00 ? 7:30 AM

GOLD RUSH BALLROOM, HOLIDAY INN GOLDEN GATEWAYOpening for the Industry Sponsored Breakfast Session on Thursday, April 20, 2017, the Exhibits will be open throughout the conference, with peak times during all coffee breaks as well as the Thursday evening e-Poster Session Reception. Industry Sponsored Breakfast & Lunch Sessions will talso ake place in the Exhibit Ballroom .

GOLD RUSH BALLROOM, HOLIDAY INN GOLDEN GATEWAY

All sponsored breakfast and lunch sessions as well as 18 tabletop exhibits, coffee breaks, poster reception and e-Posters will be held in the 5,400 square foot Gold Rush Ballroom and its foyer. The CME Sessions as well as the Immuno-oncology CRO Prespective and the Industry - Regulatory - Academic Town Hall Non-CME Educational Sessions will be held directly above the Gold Rush Ballroom in the 5,600 square foot Emerald Ballroom.

Potent ial Lunch or Breakfast Industry Sponsored Session Topics of interest to the Organizing Commit tee:

- Novel Imaging Modalit ies for Sentinel Lymph Node Identif ication and Resection RESERVED LUNCH

- Regional Therapies in Melanoma- Metastatic Biomarker Discovery LUNCH SESSION

SPONSORED BY CASTLE BIOSCIENCES, INC.- Adoptive Cell Therapies- Update on latest clinical trials- Lymphedema Topic

PREMIUM SUPPORT PACKAGES

Platinum Sponsorship: INCLUDES either an unopposed Non-CME Educational Lunch Session including Food & Beverage, meeting room, A/V and digital capture for Virtual Meeting for up to 280 participants OR acknowledgment as sponsors of the Gala Dinner

- AND a tabletop exhibit with up to 4 badges for company reps, - AND acknowledgement of support for 1st, 2nd & 3rd Place Young Investigator OR Trainee Awards - AND e-Poster sponsorship

Total Platinum Sponsorship: $50,000

Gold Sponsorship: INCLUDES either an unopposed Non-CME Educational Breakfast Session including Food & Beverage, meeting room, A/V and digital capture for Virtual Meeting or up to 280 participants OR acknowledgment as sponsors of the Wine & Cheese Poster Reception

- AND a tabletop exhibit with up to 3 badges for company reps, - AND acknowledgement of support for 1st, 2nd & 3rd Place Young Investigator OR Trainee Awards <- AND Logo Memory Sticks with Syllabus, Speaker & e-Poster Presentations

Total Gold Sponsorship: $30,000

Silver sponsorship: INCLUDES acknowledgment as sponsors of 2 sponsored theme coffee breaks OR sponsorship of the unopposed Non-CME Town Hall Session and digital capture for Virtual Meeting (first come first served),

- AND a tabletop exhibit with up to 2 badges for company reps, - AND Wireless Internet for all participants, including a charging station - AND Badge Lanyards

Total Gold Sponsorship: $20,000

INCLUSIVE PREMIUM SUPPORT PACKAGES

SINGLE SUPPORT OPPORTUNITIES: (if not taken by Platinum/Gold/Silver Sponsors)

1. Gala Dinner for up to 400 participants on Friday Evening in China Town, $25,000.2. Unopposed Non-CME Educational Lunch Session, includes food, AV, meeting room up to 280 participants: $25,000. Supporter is

responsible for speaker costs and needs to organize the session in conjunction with a member of the Cancer Metastasis Organizing Committee. Sponsorship includes digitally capturing the session which will be included on the Cancer Metastasis Virtual Meeting at www.cancermetastasis.org (enduring).

3. Unopposed Non-CME Educational Breakfast Session, includes food, AV, meeting room up to 280 participants: $15,000. Supporter is responsible for speaker costs and needs to organize the session in conjunction with a member of the Cancer Metastasis Organizing Committee. Sponsorship includes digitally capturing the session which will be included on the Cancer Metastasis Virtual Meeting at www.cancermetastasis.org (enduring).

4. Wine & Poster Reception for up to 400 participants on Thursday Evening, $15,000 5. Acknowledgement of support e-Poster Technology & Flatscreens (enduring): $15,000 6. Tote Bags, $10,000 7. Wireless Internet for all participants, including a Logo Charging Station, $7,500 8. Logo Memory Sticks with Syllabus, Speaker & e-Poster Presentations & Abstracts (enduring), $5,000 9. Acknowledgement of support of Young Investigator OR Trainee 1st, 2nd and 3rd Place Abstract Awards, $3,00010. Badge Lanyards, $5,000 11. Water Bottles, $5,000 12. Water Cooler, $2,500 13. Acknowledgment as sponsor of one Theme Coffee Break. $3,500 14. Tote Bag Inserts, $750               15. Acknowledgement of support of the Virtual Meeting, digital capture of most presentations (speaker permitted), $10,000 16. Acknowledgement of support of the Mobile App, $3,000

SINGLE ITEM SUPPORT

Along with other benefits of associating with this premier academic conference that follows the journey of cancer metastasis from detection at the molecular level to genomic identification to precision treatment & survival, all supporting companies will receive a dedicated page on www.cancermetastasis.org, to include information such as:

- Company profile, website link, logo- Pictures- Documents, open access manuscripts- Videos- Presentations- Brochures- Other relevant information of interest to participants of Cancer Metastasis 2017- Inclusion in the Symposium Social Media (Facebook, LinkedIn and Twitter).

Other benefits of support:

- Logo to be included on signage near the Exhibit Hall Entrance and on specific items that are being supported;- Acknowledgement in the Symposium Final Program on USB & the Schedule at a Glance - Use of Symposium logo for supporter?s own promotional purposes (must be approved by the Organizing Committee); - Pre & post registration lists identifying attendees names, affiliations & addresses (not applicable for Tote Bag Insert Item).- Assistance with registration at sponsored sessions. - Continued presence on www.cancermetastasis.org Virtual Meeting.

Please contact Joan Oefner at joefner@cancermetastasis.org to discuss your ideas for a customized support package that would best fit the needs of your company. All sponsors & exhibitors paying in full by June 5, 2016 will receive a 5% discount off the listed prices. The Cancer Metastasis through the Lymphovascular System: Biology & Treatment, 7th International Symposium is sponsored by the Sentinel Node Oncology Foundation which is incorporated as a 501 (c) 3 non-profit organization. Tax ID is 20-0173930.

SUPPORT BENEFITS